Right HemicolectomyNCT04628182
The China Laparoscopic Right Hemicolectomy SNAPSHOT
An observational study of Right Hemicolectomy and Colon Cancer, run by Beijing Friendship Hospital at 1 site in China.
Trial summary
The main objective is to explore the current practice of right hemicolectomy for colon cancer located in the ascending colon and hepatic flexure in selected Chinese high quality and high volume centres. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Right Hemicolectomy, Colon Cancer
- How many people
- 1,579 participants
- Where
- 1 siteChina
- Study dates
- 1 Sep 2021to 30 Jun 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Participants with non-metastasized right sided colon cancer without ingrowth into other organs suitable for elective radical resection of the ascending colon.
Who may be able to join
- Segmental right sided hemicolectomy (including extended)
- Cancer stage 1-3 (CT-staged)
- No prior abdominal surgery
Who cannot join
- Stage cT4b, perforated disease
- Acute obstruction
- Emergency surgery
- Right hemicolectomy or ileocaecal resection as part of a large procedure such as subtotal colectomy or panproctocolectomy
- Patients with inflammatory bowel disease (Crohn's disease or ulcerative colitis)
Trial locations and contacts
1 site in 1 country.
China1 site, 1 recruiting
- Recruiting
Beijing Friendship Hospital
Beijing, Beijing Municipality, 100050
Hongwei Yao, M.D., +8613611015609, yaohongwei@medmail.com.cn
About this study
The main objective is to explore the current practice of right hemicolectomy for colon cancer located in the ascending colon and hepatic flexure in selected Chinese high quality and high volume centres. This study will identify a potential area to improve the level of standard care and serve as a reference cohort to which planned standardization and addition of innovative aspects can be compared to
- Conditions
- Right Hemicolectomy, Colon Cancer
- Medical subject headings
- Colonic Neoplasms
What is being measured
The primary outcome is the main question the study is designed to answer.
post-operative anastomotic leakages
Number of post-operative anastomotic leakages within 30 days.
Measured: 1 month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Nov 2020
- Study start1 Sep 2021
- Primary completion28 Jun 2022
- Study completion30 Jun 2022 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Right HemicolectomyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 1,579 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Beijing Friendship Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Zhongtao Zhang, Beijing Friendship Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04628182
- Sponsor's protocol ID
- BFH SNAPSHOT
- Status last verified
- Jun 2022
- First submitted
- 9 Nov 2020
- Last updated
- 30 Jun 2022
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 30 Jun 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The China Laparoscopic Right Hemicolectomy SNAPSHOT
- ClinicalTrials.gov ID
- NCT04628182
- Acronym / sponsor ID
- BFH SNAPSHOT
- Conditions
- Right Hemicolectomy, Colon Cancer
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 1,579 participants (estimated)
- Lead sponsor
- Beijing Friendship HospitalUniversity, hospital or other
- Study start
- 1 Sep 2021 (actual)
- Primary completion
- 28 Jun 2022 (actual)
- Study completion
- 30 Jun 2022 (estimated)
- First posted
- 13 Nov 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The main objective is to explore the current practice of right hemicolectomy for colon cancer located in the ascending colon and hepatic flexure in selected Chinese high quality and high volume centres. This study will identify a potential area to improve the level of standard care and serve as a reference cohort to which planned standardization and addition of innovative aspects can be compared to
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Participants with non-metastasized right sided colon cancer without ingrowth into other organs suitable for elective radical resection of the ascending colon.
Key inclusion criteria (3 listed)
- Segmental right sided hemicolectomy (including extended)
- Cancer stage 1-3 (CT-staged)
- No prior abdominal surgery
Key exclusion criteria (5 listed)
- Stage cT4b, perforated disease
- Acute obstruction
- Emergency surgery
- Right hemicolectomy or ileocaecal resection as part of a large procedure such as subtotal colectomy or panproctocolectomy
- Patients with inflammatory bowel disease (Crohn's disease or ulcerative colitis)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
post-operative anastomotic leakages
Time frame: 1 month
Number of post-operative anastomotic leakages within 30 days.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Jun 2022.
Related trials for Right Hemicolectomy
RecruitingObservational study
Robotic Assisted Right Colectomy With the DEXTER Robotic Surgery System
Right Colectomy
Not yet recruitingObservational study
Multicenter Prospective Study Protocol for Validating Surgical Quality Standards in D3 Lymphadenectomy for Oncological Right Hemicolectomy
Colon Neoplasms, Right Colon Tumors
Not yet recruitingObservational study
Mechanical Resistance Curves of the NTLC75 Linear Stapler During Barcelona Ileotransverse Anastomosis
Right Colon Cancer
RecruitingObservational study
Chronic Loose Stools Following Right-sided Hemicolectomy for Colon Cancer and the Association With Bile Acid Malabsorption and Small Intestinal Bacterial Overgrowth Using a Novel Sampling Device
Colon Cancer
RecruitingObservational study
Leakage Rate of Ileo-COlic Sutured Anastomosis After Right Hemicolectomy
Anastomotic Leak, Colon Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Right Hemicolectomy and Colon Cancer, run by Beijing Friendship Hospital at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 30 Jun 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
post-operative anastomotic leakages (time frame: 1 month). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jun 2022.